July 1, 2021
Taisho Pharmaceutical said on June 30 that it has signed an exclusive license agreement giving US-based Ancora Bio the worldwide rights to develop, manufacture, and market its antidepressant TS-121, which is currently undergoing a PIIa clinical trial in the US...read more